Document Type
Article
Publication Date
11-20-2024
Abstract
In 2023, the United States experienced the most significant increase in prescription drug spending (13.6%), totaling $89 billion.1 This was driven by higher utilization and the introduction of new, expensive specialty and biotech drugs. In 2024, other factors continue to drive costs and disrupt the pharmacy landscape, including the implementation of new business models, pharmacy benefit manager (PBM) practices, the rebate system, regulatory changes, advancements in provider status, and potential Federal Trade Commission (FTC) interventions.
Recommended Citation
Kimble C, Pile T, & Coustasse A. Payment Disrupters and Opportunities: Key Trends that Impacted Pharmacy in 2024. Pharmacy Times 13.6, Nov. 2024;22-23.
Included in
Business Administration, Management, and Operations Commons, Pharmacoeconomics and Pharmaceutical Economics Commons, Pharmacy Administration, Policy and Regulation Commons
Comments
The copy of record with endnotes is available from the publisher at https://www.pharmacytimes.com/view/payment-disrupters-and-opportunities-key-trends-that-impacted-pharmacy-in-2024. Copyright 2024 Pharmacy Times. Reprinted with permission.